Latest AMD Stories
A team of researchers, including a scientist from the Viral Immunology Center at Georgia State University, have found that a type of herpesvirus infection of the eye is associated with neovascular age-related macular degeneration (AMD), a disease that causes blindness in the elderly. The scientists found that human cytomegalovirus, a type of herpesvirus, causes the production of vascular endothelial growth factor, or VEGF, a signal protein that regulates the formation of new blood vessels....
SAN FRANCISCO and HOUSTON, May 16, 2012 /PRNewswire/ -- Avalanche Biotechnologies, Inc., a leader in the area of long-term protein delivery for ocular diseases, and Lonza, a global leader in the field of biologics manufacturing, today announced a manufacturing collaboration focused on process development and scale-up efforts for the manufacturing of adeno-associated viral (AAV) vectors for gene therapy. AAV vectors are rapidly becoming one of the most promising gene delivery...
BEIJING, May 14, 2012 /PRNewswire-Asia/ -- DVD movies play an important role in the lives of many people, but the restrictions on DVD drivers are often quite confusing. And so, Tipard's newly updated DVD Ripper makes a great assistant for those looking to solve this issue. As the most professional DVD Ripper, it can easily help users rip their beloved DVD movies to all the popular video (including HD Video) and audio formats with breathtaking speed while maintaining the high quality...
Clinical studies in retinal diseases scheduled to begin in second half 2012 Gene Signal, a company focused on developing innovative drugs to manage angiogenesis based conditions, today announced that positive data from a study of aganirsen (GS-101, eye drops) in a nonhuman primate model of choroidal neovascularization has been presented at the 2012 ARVO Annual Meeting in Fort Lauderdale, Florida. Topical administration of aganirsen was found to inhibit neovascular growth and leakage in...
TARRYTOWN, N.Y., May 8, 2012 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) and Bayer HealthCare today announced that Bayer's Japanese subsidiary, Bayer Yakuhin, Ltd. ("Bayer Yakuhin"), and Santen Pharmaceutical Co., Ltd.?"Santen"?entered into a co-promotion agreement for EYLEA® (aflibercept) Injection in Japan. As previously announced, Bayer Yakuhin has submitted an application for marketing authorization to the Ministry of Health, Labor and Welfare (MHLW) for...
Image Credit: Photos.com --- Connie K. Ho for RedOrbit.com Mark your calendars: May is Healthy Vision Month. Since 2003, the National Eye Institute (NEI) has promoted May with this national eye health observance. During Health Vision Month, NEI hopes to increase awareness about early diagnosis and treatment of vision loss. The NEI, under the National Institute of Health (NIH), helps develop the federal government’s research on the visual system and eye diseases. The NIH is the...
American Health Assistance Foundation Calls for Greater Investment in Research to Halt Eye Disease This week, the second-year results of an important clinical trial on age-related macular degeneration (AMD), known as the Comparison of AMD Treatments Trials (or CATT), were published in the journal Ophthalmology. Researchers found that two drugs known as Avastin (bevacizumab) and Lucentis (ranibizumab), commonly used to treat the wet form of AMD, were similarly effective in maintaining...
Year 2 results corroborate initial findings that 2 medications provide strikingly similar results Two drugs commonly used to treat age-related macular degeneration (AMD) yield similar improvements in vision for patients receiving treatments on a monthly or as-needed basis, according to a study from researchers at the Center for Preventive Ophthalmology and Biostatistics (CPOB) at the Perelman School of Medicine at the University of Pennsylvania. The year-two results of the Comparison of...
At two years, Avastin (bevacizumab) and Lucentis (ranibizumab injection), two widely used drugs to treat age-related macular degeneration (AMD), improve vision when administered monthly or on an as needed basis, although greater improvements in vision were seen with monthly administration for this common, debilitating eye disease, according to researchers supported by the National Institutes of Health. Of the two drugs, Avastin is most frequently used to treat AMD. However, prior to the...
PRINCETON, N.J., April 19, 2012 /PRNewswire/ -- Next Inning Technology Research (http://www.nextinning.com), an online investment newsletter focused on semiconductor and technology stocks, has published updated outlooks for Apple (Nasdaq: AAPL), Advanced Micro Devices (NYSE: AMD), Lattice Semiconductor (Nasdaq: LSCC), SanDisk (Nasdaq: SNDK), and MIPS Technologies (Nasdaq: MIPS). Editor Paul McWilliams spent a decades-long career in the technology industry, and has earned a...
